← Back to SCNI

Scinai Immunotherapeutics Ltd. - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2023Filed 18/08/2023Mar 2023Filed 15/05/2023Jun 2022Filed 18/08/2023Mar 2022Filed 15/05/2023
−$3.8−$3.5−$3−$2.5
−$0.00−$0.00−$0.00−$0.00
1,3521,295747745

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.